# Ground Truth Medical Form (GTMF)

## Patient Information

- **Subject ID**: 8771
- **Admission ID**: 176766
- **Row ID**: 1688
- **Profile Type**: FULL

## Demographics

- **Age**: 48
- **Sex**: F
- **Date of Birth**: 2069-09-17
- **Ethnicity**: BLACK/AFRICAN AMERICAN
- **Marital Status**: SINGLE
- **Religion**: BAPTIST
- **Insurance**: Private
- **Admission Type**: ELECTIVE
- **Admission Date**: 2117-11-19 07:45:00
- **Discharge Date**: 2117-11-24 17:13:00

## Chief Complaint

chronic discomfort and pain from enlarged uterus due to uterine fibroids

## Symptoms

- **chronic discomfort from enlarged uterus including pain with bending and movement** | duration: chronic | severity: significant
- **hot flashes**

## Medical History

Seizure disorder (last seizure in 2106), environmental allergic reaction

## Allergies

environmental allergic reaction

## Current Medications

- **Dilantin** | dosage: 100 mg | frequency: po b.i.d. | purpose: seizure disorder management
- **Zyrtec** | frequency: daily | purpose: environmental allergy management
- **Dilantin** | dosage: 400 mg po q day (immediate postop), previously 100 mg po t.i.d. | frequency: q day (immediate postop), previously t.i.d. | purpose: Seizure prophylaxis
- **Protonix** | purpose: Gastric protection
- **Heparin** | dosage: 5000 units | frequency: b.i.d. | purpose: DVT prophylaxis

## Discharge Medications

- **Protonix** | dosage: 40 mg | frequency: po q day
- **Dilantin** | dosage: 100 mg | frequency: po b.i.d.
- **Zyrtec** | dosage: 10 mg | frequency: po q day
- **Motrin** | dosage: 600 mg | frequency: po q 6 hours prn pain
- **Percocet** | dosage: 5/325 mg, one to two tablets | frequency: po q 4 to 6 hours prn pain
- **Niferex** | dosage: 150 mg | frequency: po q day
- **Multivitamin with iron**

## Diagnoses

- **uterine fibroids** | notes: Enlarged uterus extending up to the umbilical level
- **perimenopausal ovarian status** | notes: FSH level of 39 units
- **seizure disorder** | notes: Last seizure in 2106
- **ileus (postoperative, resolved)** | notes: Occurred on postop day one and two, resolved by day three and four

## Treatment Options

### supracervical hysterectomy

**Details**: Performed on 2117-11-19 for uterine fibroids

### bilateral salpingo-oophorectomy

**Details**: Prophylactic oophorectomy at time of hysterectomy

### evaluation of left ureteral patency

**Details**: Included pelvic ureteral 3 mm ureterotomy with antegrade left ureterogram and cystogram; ureterotomy closed with 4-0 vicryl and JP drain placed

### transfusion of packed red blood cells

**Details**: 2 units given intraoperatively

### postoperative pain management

**Details**: Initially Dilaudid PCA pump, then Motrin and occasional percocet by postoperative day four

**Medications**:
- Dilaudid (not provided)
- Motrin (not provided)
- Percocet (not provided)

### Prophylactic antibiotics during surgery

**Details**: Received 2 doses of Cefazolin during surgery, no antibiotics after surgery.
**Treatment**: Cefazolin

**Medications**:
- Cefazolin (2 doses)

### Deep venous thrombosis prophylaxis

**Details**: Heparin subQ 5000 b.i.d. and pneumoboots.
**Treatment**: Heparin and pneumoboots

**Medications**:
- Heparin (5000 units)

### Gastric protection

**Details**: Protonix administered to protect stomach.
**Treatment**: Protonix

**Medications**:
- Protonix (not provided)

### JP drain placement

**Details**: JP drain placed in left pelvic cul-de-sac to monitor ureterotomy repair.
**Treatment**: JP drain

### Foley catheter placement

**Details**: Foley catheter placed in bladder for four days postop to reduce tension on ureterotomy repair.
**Treatment**: Foley catheter

### Ureterotomy repair

**Details**: 3 mm intentional ureterotomy oversewn after antegrade cystogram with 4-0 vicryl.
**Treatment**: Surgical repair
